Board of Directors
As a corporately driven organization, the MedTech Board of Directors is comprised of senior officers of our member companies.
Scott Gucciardi, Chair
Adjunct Professor, Syracuse University and President, EagleDream Health Inc.
Scott Gucciardi has 25 years of experience in the global medical technology business and held a variety of executive leadership positions in his tenure at Welch Allyn. Scott is adjunct professor of entrepreneurship at Syracuse University’s Whitman School of Management and an instructor in the Boots2Business program of the Institute for Veterans and Military Families. He is chief business development officer at EagleDream Health Inc., an early stage big data analytics technology company. He is also board chairman of MedTech Association, an advisor to three healthcare start-up companies and a director on the board of Liberty Resources, a diversified human services agency serving New York and Texas. Scott has a bachelor’s degree in mechanical engineering from Clarkson University and an MBA from the Simon Business School at University of Rochester.
Jeffrey Trubia, Treasurer
Partner, The Bonadio Group
As a partner at The Bonadio Group, Jeffrey Trubia provides expertise in accounting, tax consulting and business management to a diverse for-profit client base. With more than 16 years of experience, he specializes in working with the following industries: healthcare, manufacturing, real estate development and equipment, as well as construction. Trubia is able to maximize a client’s potential by offering analyses of overall profitability and developing a customized strategic action plan for their future. He is known for his strong personal skills and the energy he brings to helping TMD’s clients succeed. Trubia received his education at Le Moyne College.
Paul Buckley, Secretary
President, Applied Sciences Group
Paul Buckley has been president of Applied Sciences Group (ASG) since 1997, serving in engineering, operations management and strategic development areas. Prior to his employment at ASG, Buckley worked in the aerospace and telecommunications industries in various engineering and management capacities. He currently chairs the University at Buffalo's Center for Entrepreneurial Leadership (CEL) Alumni Association and is the 2004 CEL Taylor Kew Award Recipient for Entrepreneurial Excellence. He is a board member of the Buffalo Niagara Partnership, the UB School of Medicine's Dean's Council and the Buffalo branch of the American Diabetes Association. He has a bachelor's degree in Bio-medical Engineering and a master’s degree in Systems Engineering from RPI.
Senior Director, Ortho Clinical Diagnostics
Dan Carlson is the senior director of Rochester Site Operations for Ortho Clinical Diagnostics (OCD). He joined the company in April of 2014, bringing more than 30 years of operations and business experience to OCD. Carlson was most recently a senior executive with the Eastman Kodak Company, serving as the general manager for the Retail Systems Solutions (RSS) Picture Kiosk business. Carlson graduated from Michigan Technological University with a bachelor’s in Electrical Engineering.
President, Novatek Communications
Amy Castronova combines the thoughtfulness and precision of an engineer with the personality and energy of a natural-born leader. As President and CEO of Novatek, her professional and leadership skills have been challenged and awarded with many honors. In recent years, Castronova has been awarded Rochester Business Person of the Year, finalist for Technology Woman of the Year, and Rising Star of the Women Presidents Organization, an organization for women presidents of multimillion-dollar companies across the US and Canada. She was also awarded the Young Entrepreneur Champion of the Year, at the district, state, and regional level by the U.S. Small Business Administration. Castronova was invited to the White House to be recognized as one of the top 100 companies run by young entrepreneurs age 30 or younger who impact our economy, where she gave a brief speech on the importance of entrepreneurship.
Director of Business Development, MPR Associates
Jeff Champagne is the director of business development at MPR Associates. Specializing in emerging technologies and research and development, he is able to help clients gain perspective, define company and product road maps, navigate obstacles and realize objectives to speed up commercialization efforts. As a trusted management consultant, his clients include top executives at the most innovative companies, the most prolific research institutions in the world and many Fortune 500 companies. Champagne has a background in marketing and business development, with a master’s from the University of Hartford.
Greg Gdowski, Ph.D.
Executive Director, CMTI, University of Rochester
Dr. Greg Gdowski is the executive director of the Center of Medical Technology and Innovation (CMTI) at the University of Rochester. With a background in both academic research and industry/incubation settings, he was most recently a senior research engineering fellow at Blue Highway, where he managed ideation, invention, incubation and subsequent innovation opportunities. He also served on the faculty in Biomedical Engineering at the University of Rochester from 2001-2010 where he established and managed a NIH-funded research laboratory in vestibular sensory processing. Dr. Gdowski received his bachelor’s, master’s and doctorate in Biomedical Engineering at Boston University, and his post-doctorate in Neuroscience at the University of Chicago.
James Grabowski, Ph.D.
Vice President, Supply Chain – API, Albany Molecular Research Inc.
James Grabowski, Ph.D., is director, mergers and acquisitions at Albany Molecular Research Inc. (AMRI) in Albany, N.Y. Dr. Grabowski has held a number of roles of increasing importance with experience managing diverse, international teams within AMRI since joining the company in 2006. His current role includes, but is not limited to, the development and analysis of an acquisition pipeline, the management of due diligence on target acquisitions and leading the integration of acquired companies. Dr. Grabowski received an MBA from the University at Albany, a Ph.D. in Organic Chemistry from Brandeis University and a bachelor's degree in Chemistry from the College of the Holy Cross.
Chief Executive Officer, Volpi Manufacturing USA
Max Kunz is the chief executive officer at Volpi, where he provides operations oversight and leads the sales and marketing efforts to propel Volpi’s OEM business in the life science and medical markets. Starting his career as an electrical apprentice in Switzerland, Kunz worked for ABB in Switzerland, both as an engineer and director of sales for the Americas. Following his time at ABB, he held different management positions for Zühlke Engineering in Switzerland before he was presented with the opportunity to take over Volpi in 2008. Kunz received bachelor’s degree in Electrical Engineering from the Polytechnic School in Winterthur/Zurich and his MBA from Nova University.
Plant Controller, Regeneron Pharmaceuticals
Jim Leggett is a plant controller for Regeneron Pharmaceuticals. In this role, he has financial responsibility for the Rensselaer Industrial Operations and Product Supply Group. Prior to Regeneron, Leggett was the global controller for the coated fabrics division of Saint-Gobain Performance Plastics, a publicly-traded French multinational building products company. With more than 20 years of experience in finance and accounting, including 6 years in public accounting as an auditor, his specialties include telecommunications, manufacturing and biopharmaceuticals manufacturing. Leggett graduated from the University of Colorado, Boulder with a bachelor's degree in Accounting. He has also held a Certified Public Accounting license since 1995.
Brian McIlroy, Ph.D.
Executive Director, Buffalo Institute for Genomics and Data Analytics, University at Buffalo
Brian McIlroy, Ph.D., took on the role of new executive director of the Buffalo Institute for Genomics and Data Analytics (BIG) at the University at Buffalo in April 2016. As executive director of BIG, Dr. McIlroy develops and implements a comprehensive plan for advancing BIG’s mission, with a focus on driving innovation and generating economic impact through industry collaboration. Dr. McIlroy was recruited to GE Global Research in May 2007 as the senior bioinstrumentation leader. He began his career at the National Medical Laser Center in London, England. While there, he was responsible for all the laser treatments and maintenance of the clinical and non-clinical laser systems. Overall, Dr. McIlroy has more than 20 years’ experience in all aspects of medical device development together with management of clinical trials ranging from preclinical through phase III FDA controlled global trials. He is a world-renowned specialist in the area of Photodynamic Dosimetry Therapy (PDT) and serves on the editorial board of Journal of Photochemistry and Photobiology B, as well as being a member of many international bodies in the areas of photochemistry and photobiology. He has published a number of articles in the peer reviewed literature, two issued patents and has been invited to speak at many international conferences. McIlroy has a Ph.D. in PDT from the National Medical Laser Center in London, England.
Chief Executive Officer, SoPark Corporation
Gerry Murak is the sole owner, chief executive officer and chairman of the board of SoPark, which is an ISO 9001:2008, AS 9100 and ISO 13485 Certified contract electronics service provider. He is also the founder, president and chief executive officer of a new high tech venture, Precision Scientific Instruments, Inc. (PSi™), which is commercializing disruptive US patented technology. Prior to starting his management consulting firm, Murak & Associates LLC in 1991, he turned around the performance within two different locations of a Fortune 500 FDA regulated corporation, as well as a Top 100 Western New York corporation. He is currently a member of the University at Buffalo (UB) School of Management (SOM) Dean’s Advisory Council and a Director on the UB SOM Alumni Board. Murak has a master’s and an MBA and is a Certified Professional in Human Resources. He also serves as a professional speaker and is the author of several journal articles.
Assistant General Counsel, CONMED Corporation
Sarah Oliker is the assistant general counsel at CONMED Corporation. In this role, she advises on international and domestic distribution matters, health care provider arrangements and provides strategic counsel on day-to-day matters affecting CONMED’s business. Oliker has more than 15 years of healthcare experience. Prior to CONMED, she served as senior counsel for ProCure Treatment Centers, Inc., where she structured complex physician arrangements and hospital joint ventures, provided health care regulatory and reimbursement counsel, as well as overseeing the Corporate Compliance Program. Prior to ProCure, Oliker spent five years with Epstein Becker & Green in its Health Care & Life Sciences group based in Washington, D.C., where her practice consisted of health regulatory and transactional matters, representing clients from all verticals of the health care industry. She is currently admitted to practice in Washington, D.C. and New York and is a member of the American Health Lawyers Association. She also serves as president of the Syracuse University Law Alumni Association. Oliker holds a bachelor’s from Colgate University and earned her JD at Syracuse University College of Law.
President & CEO, Efferent Labs, Inc.
Bill Rader is the president and CEO of Efferent Labs, Inc., a pre-clinical stage company focused on biosensor systems for life science. A serial entrepreneur, Rader sold his first company at age 18. To date he has launched five ventures, including the most recent Efferent Labs and orchestrated multiple mergers and acquisitions. In October 2014, Efferent Labs was a winner in the world’s largest business contest, 43North. Rader started in the engineering sector of the U.S. Navy as a nuclear engineering member of the Submarine Fleet and is a member of many industry organizations. He is also a contributing writer for Forbes, where he writes on entrepreneurship and business. Rader holds a bachelor’s degree in Electrical Engineering and is a graduate of the University at Buffalo School of Management. He is also a member of Harvard Business School, Business Innovations in Global Healthcare class of 2015.
M. Jack Rudnick
Counsel, Barclay Damon
M. Jack Rudnick is counsel with Barclay Damon, LLP on their Emerging Technology Team, where he provides business and legal consultation to technology-based companies. He is experienced in corporate and intellectual property law and has been providing legal counsel for over 40 years. Rudnick co-founded Blue Highway, Inc. while at Welch Allyn, Inc. to locate and accelerate the development of technologies with medical applications. He served as Blue Highway's senior vice president of legal and government affairs. Rudnick is also the director of the New York State Science & Technology Law Center at Syracuse University, with long-term experience as an adjunct professor. He serves on the Advisory Board of CNY Biotech Accelerator as well as and the Lally School (RPI) Advisory Board for Technology Commercialization and Entrepreneurship. He is an active member of the American and New York State Bar Associations. Rudnick earned his bachelor’s in Political Science and History from Middlebury College and his JD from Syracuse University College of Law.
Business Development Manager, Sparton Medical
Kevin Webb is the business development manager for the Great Lakes Region for Sparton Corporation, a specialized contract development and manufacturer for complex classification II & III medical instrumentation and other highly regulated industries. For the past thirteen years, his main role and passion at Sparton has been engaging with clients, cross-functional teams and supplier-partners to help launch “first-of-kind” medical technologies. Prior to Sparton, Webb has more than ten years of direct sales, marketing, distribution and operations for global product launch campaigns. Webb is from a family of inventors and received his B.S.B.A from the University of West Florida.
Chief Executive Officer, Clark Laboratories, Chief Operations Officer, Immco Diagnostics
Chad Werts is the chief executive officer of Clark Laboratories and the chief operations officer of Immco Diagnostics, both subsidiaries of Trinity Biotech Plc. He joined Immco in 2010, bringing a diverse engineering and operations background from both automotive and medical device industries. His expertise in lean manufacturing has lead to significant improvements within Immco and Clark, including but not limited to decreased inventory and obsolescence and improved order turn-around time to customers. Werts has held international assignments in Germany and England. He holds a bachelor's degree in Mechanical Engineering from Clemson University.
Associate Director Client Services & Director of Business Development, Axon Communications
Jennifer M. Barrett, MSc is an experienced health communication professional dedicated to improving health outcomes. She has focused her career on building awareness through health education, marketing and rebranding initiatives that result in behavior modification. She develops creative strategic communication and marketing plans that address disease prevention, health promotion, patient advocacy and support, improvements in quality of care, as well as educating on the social model of patient care. She has been an integral leader in health collaboration initiatives providing unique solutions to address evolving health care industry trends.
Jennifer received her undergraduate degree from Fairfield University and holds a Master of Science in Health Communication from Boston University. She is active in her industry as a member of CURE and Healthcare Business Women’s Association.
President & CEO, iuvo BioScience
Prior to co-founding iuvo BioScience and taking on the roles of President and CEO, Ben was Vice President of Quality for the Pharmaceutical, Solutions and External Manufacturing organizations of Valeant Pharmaceuticals. Prior to the acquisition of Bausch + Lomb by Valeant, Ben served as Global VP of Quality for the Pharmaceutical Business Unit, and was a member of the B+L Global Leadership Team.
Earlier in his career, he held the position of Director, Quality and Technical Services for Norwich Pharmaceuticals, responsible for driving new business development and revenue and leading the technical services organization in delivering customer projects, as well as heading up the site quality organization. Ben began his career with Procter & Gamble Pharmaceuticals as a Process Engineer, moving up to roles of increasing responsibility in Product Development, OTC Engineering (Cayey, PR) and Global Clinical Supplies.
Ben holds a BS from Carnegie Mellon University with a double major in Chemical Engineering and Biomedical Engineering, and a dual MS/MAT in Chemistry and Education from Binghamton University.
CNY Biotech Accelerator, Director of Operations and Innovation Partnerships
Kathi Durdon, MA, CCRP, is Director of Operations and Innovation Partnerships at the CNY Biotech Accelerator (CNYBAC), a division of Upstate Medical University in Syracuse, NY.
As Director of CNYBAC, Kathi promotes effective and transparent operational procedures for the 60,000 square foot specialized multi-use biotech facility, CNYBAC. She develops biotech innovation-oriented programs, coordinates resources and promotes educational and investment opportunities for clients and the startup community and mentors medical device innovators relative to Good Clinical Practice regulations, FDA submission requirements and device classification as well as human factors usability testing.
Kathi holds Bachelor’s degrees in English and Anthropology and a Master’s degree in Business. Previously, Kathi was employed at Welch Allyn, a medical device manufacturer, as Manager of Clinical Affairs and as Director, Clinical Trials at SUNY Upstate Medical University.
Irfan Khan, MD
Founder & Chief Strategy Officer, Circuit Clinical
Irfan Khan is the Founder and Chief Strategy Officer of Circuit Clinical - a rapidly scaling clinical research site network powered by proprietary data management software. In this role he is responsible for Circuit's strategic positioning and all business development and industry engagement. He has also been a clinical research investigator for almost 15 years and as a partner in Buffalo Heart Group built its electrophysiology clinical research program. Dr. Khan is a Board Certified clinical cardiac electrophysiologist trained at Case Western Reserve University and has performed thousands of cardiac procedures in his past role as the Director of the Electrophysiology program at Mercy Hospital of Buffalo. Dr. Khan is a passionate advocate for patient education and responsibility and speaks frequently on these topics, including a 2014 TEDx appearance on prevention of sudden death.
Vice President, Tanner-Ibbotson, Inc.
Brian Toglia is currently a partner and life science practice leader at Tanner-Ibbotson, Inc. In this role, he advises clients on their various exposures to loss during each phase of business development and leverages his relationship in the marketplace to deliver comprehensive insurance solutions. Toglia has 12 years of risk management experience and has been specifically focusing on the life science industry since 2013. His practice has expanded beyond the borders of New York State where he is currently licensed in 12 states and growing.
Beyond his role at Tanner-Ibbotson, Toglia is actively involved in the life science community, particularly in NY. In 2016, he was named MedTech Association Member of the Year in recognition of his contributions to the industry. He also serves on the advisory council for the Binghamton University School of Pharmacy & Pharmaceutical Studies.
Toglia holds 2 bachelor degrees from Pepperdine University in Business and Political Science.
Director, The Kevin M. McGovern Family Center for Venture Development in the Life Sciences, Cornell University
Lou Walcer was appointed in June 2011 as the first Director of the Kevin M. McGovern Family Center for Venture Development in the Life Sciences at Cornell University. Lou’s career spans 40 years in drug, medical device, vaccine, and diagnostic product development as Entrepreneur, Consultant, Manager, Director, Company Officer and President.
From 2006-2011, Lou had served as Consultant to, then Senior Commercialization Executive for New Ventures at Cleveland Clinic Innovations where he managed a portfolio of 30 startups, and planned, created and obtained initial investment funding for 10, which eventually netted two licenses, one IPO, and 3 exits by sale for that institution.
Lou earned a B.A. degree from Cornell University, and his M.B.A. from New York University. He has served as Director, Vice Chair, and Chairman of the Board of Directors of the Business Incubator Association of New York State